SPATIAL PROTEOMICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Key Developments:

• On December 11, 2024, Syncell, a leader in next-generation subcellular protein purification and spatial proteomics, announced the closure of a US$ 15 million Series A funding round, bringing its total raised to US$ 30 million. The investment, led by Taiwania Capital, a venture capital firm, will support the global commercialization of its Microscoop platform. In 2024, Syncell plans to expand with instrument placements in the U.S., Europe, and Asia Pacific, and open new offices in the U.S. and Taiwan.
• On December 9, 2024, Akoya Biosciences, Inc., a spatial biology company, announced that Nature Methods, one of the world's leading scientific journals, had named spatial proteomics as its “Method of the Year 2024,” recognizing its transformative potential in advancing biological research and medicine. Akoya, a leader in spatial proteomics with the largest installed base of 1,300 instruments, celebrates this achievement as a reflection of the technology's impact.
• In September 2024, Lunaphore, a spatial biology brand under Bio-Techne Corporation, a biotech company, announced a partnership with Discovery Life Sciences, a global leader in biospecimen solutions, to introduce their spatial biology platform, COMET, to enhance clinical research efforts.
• In September 2023, NanoString Technologies, Inc., a biotechnology company, launched a new assay for its GeoMx Digital Spatial Profiler (DSP) platform. The GeoMx IO Proteome Atlas (IPA) is the most comprehensive spatial proteomics assay in the industry, capable of spatially profiling over 500 immuno-oncology (IO) relevant targets from Formalin-Fixed, Paraffin-Embedded (FFPE) tissue sections.
• In July 2023, Cayman Chemical, a global life sciences supplier, formed a strategic alliance with Navinci Diagnostics, a biotechnology company. This collaboration provides researchers in the U.S. and Canada with greater access to Navinci's proximity ligation-based spatial proteomics solutions, leveraging Cayman's extensive customer base and catalog of over 20,000 products.

Top Strategies Followed by Global Spatial Proteomics Market Players

• Established Players: Leading companies are investing heavily in research and development to innovate high-performance products
  • For instance, in February 2023, Curio Bioscience launched Curio Seeker, a high-resolution, whole-transcriptome spatial mapping kit, marking the company's entry into the spatial proteomics market
• Mid-Level Players: Mid-level companies are focusing on delivering quality, budget-friendly products targeting price-sensitive consumers
  • For example, Syncell Inc., founded in 2020, offers the Microscoop platform for high-precision, unbiased spatial proteomics analysis, providing cost-effective solutions for subcellular protein purification
• Small-Scale Players: Small players target niche markets with unique features. Pixelgen Technologies, founded in 2020, focuses on single-cell spatial proteomics with its Molecular Pixelation technology, catering to specialized research needs.

Emerging Startups - Spatial Proteomics Industry Ecosystem

• Startups like Pixelgen Technologies are developing advanced technologies such as Molecular Pixelation for single-cell spatial proteomics, enabling high-multiplex, 3D spatial analysis of cell surfaces. These technologies have the potential to significantly influence market dynamics by providing researchers with more detailed and accurate spatial protein data, thereby advancing the field of proteomics and personalized medicine.
• Companies such as NanoString Technologies are focusing on sustainability by creating eco-friendly spatial proteomics products. This approach contributes to reducing the industry’s environmental footprint and aligns with global sustainability trends.
• Startups are addressing unique market needs by focusing on specialized areas within spatial proteomics, such as single-cell analysis or specific disease research, thereby filling gaps left by larger companies. Emerging companies often collaborate with academic institutions and established industry players to drive technological and sustainable innovation, enhancing their research capabilities and market presence.

• 10X Genomics
• Bruker
• Fluidigm Corporation
• NanoString Technologies, Inc.
• Akoya Biosciences, Inc.
• PerkinElmer
• Danaher
• Biotechne
• S2 Genomics, Inc.
• Seven Bridges Genomics Inc.
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Hoffmann-La Roche Ltd.
• Merck KGaA